NVX-CoV2373
vaccine against COVID-19
Press Enter · cited answer in seconds
0 sources
NVX-CoV2373
Summary
NVX-CoV2373 is a funded product[1]. NVX-CoV2373 draws 119 Wikipedia views per month (funded_product category, ranking #4 of 11).[2]
Key Facts
- NVX-CoV2373's instance of is recorded as funded product[3].
- NVX-CoV2373's manufacturer is recorded as Fujifilm Diosynth Biotechnologies[4].
- NVX-CoV2373's manufacturer is recorded as SK Bioscience[5].
- NVX-CoV2373's manufacturer is recorded as Praha Vaccines[6].
- NVX-CoV2373's manufacturer is recorded as Biofabri[7].
- NVX-CoV2373's manufacturer is recorded as Takeda Pharmaceutical Company[8].
- NVX-CoV2373's manufacturer is recorded as PolyPeptide Group[9].
- NVX-CoV2373's manufacturer is recorded as Endo International plc[10].
- NVX-CoV2373's manufacturer is recorded as Biologics Manufacturing Centre[11].
- NVX-CoV2373's developer is recorded as Novavax[12].
- NVX-CoV2373's developer is recorded as Emergent BioSolutions[13].
- NVX-CoV2373's developer is recorded as Serum Institute of India[14].
- NVX-CoV2373's developer is recorded as AGC Biologics[15].
- NVX-CoV2373's subclass of is recorded as COVID-19 vaccine[16].
- NVX-CoV2373's subclass of is recorded as protein subunit vaccine[17].
- NVX-CoV2373's subclass of is recorded as vaccine candidate[18].
- NVX-CoV2373's DrugBank ID is recorded as DB15810[19].
- NVX-CoV2373's official website is recorded as https://www.novavaxcovidvaccine.com/[20].
- NVX-CoV2373's described by source is recorded as Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS (COVID-19) Nanoparticle Vaccine With/Without Matrix-M Adjuvant[21].
- NVX-CoV2373's described by source is recorded as First-in-Human Trial of a SARS CoV 2 Recombinant Spike Protein Nanoparticle Vaccine[22].
- NVX-CoV2373's described by source is recorded as A Study Looking at the Effectiveness and Safety of a COVID-19 Vaccine in South African Adults[23].
- NVX-CoV2373's described by source is recorded as A Study Looking at the Effectiveness, Immune Response, and Safety of a COVID-19 Vaccine in Adults in the United Kingdom[24].
- NVX-CoV2373's vaccine for is recorded as COVID-19[25].
- NVX-CoV2373's VIOLIN ID is recorded as 5791[26].
- NVX-CoV2373's Vaccine Ontology ID is recorded as VO_0005155[27].
Why It Matters
NVX-CoV2373 draws 119 Wikipedia views per month (funded_product category, ranking #4 of 11).[2] NVX-CoV2373 has Wikipedia articles in 19 language editions, a strong signal of global cultural recognition.[28] NVX-CoV2373 is known by 8 alternative names across languages and contexts.[29]